Al-Freah M A B, McPhail M J W, Dionigi E, Foxton M R, Auzinger G, Rela M, Wendon J A, O'Grady J G, Heneghan M A, Heaton N D, Bernal W
Institute of Liver Studies, King's College Hospital, London, UK.
Am J Transplant. 2017 May;17(5):1255-1266. doi: 10.1111/ajt.14230. Epub 2017 Apr 5.
Current diagnostic criteria for primary nonfunction (PNF) of liver grafts are based on clinical experience rather than statistical methods. A retrospective, single-center study was conducted of all adults (n = 1286) who underwent primary liver transplant (LT) 2000-2008 in our center. Laboratory variables during the first post LT week were analyzed. Forty-two patients (3.7%) had 2-week graft failure. Transplant albumin, day-1 aspartate aminotransferase (AST), day-1 lactate, day-3 bilirubin, day-3 international normalized ratio (INR), and day-7 AST were independently associated with PNF on multivariate logistic regression. PNF score =(0.000280D1AST)+ (0.361D1 Lactate)+(0.00884D3 Bilirubin)+(0.940D3 INR)+(0.00153D7 AST)-(0.0972TxAlbumin)-4.5503. Receiver operating curve analysis showed the model area under receiver operating curve (AUROC) of 0.912 (0.889-0.932) was superior to the current United Kingdom (UK) PNF criteria of 0.669 (0.634-0.704, p < 0.0001). When applied to a validation cohort (n = 386, 34.4% patients), the model had AUROC of 0.831 (0.789-0.867) compared to the UK early graft dysfunction criteria of 0.674 (0.624-0.721). The new model performed well after exclusion of patients with marginal grafts and when modified to include variables from the first three post-LT days only (AUROC of 0.818, 0.776-0.856, p = 0.001). This model is superior to the current UK PNF criteria and is based on statistical methods. The model is also applicable to recipients of all types of grafts (marginal and nonmarginal).
目前肝移植原发性无功能(PNF)的诊断标准是基于临床经验而非统计方法。对2000年至2008年在本中心接受初次肝移植(LT)的所有成年人(n = 1286)进行了一项回顾性单中心研究。分析了肝移植术后第一周的实验室变量。42例患者(3.7%)出现了2周移植肝无功能。在多因素逻辑回归分析中,移植白蛋白、第1天天冬氨酸转氨酶(AST)、第1天乳酸、第3天胆红素、第3天国际标准化比值(INR)和第7天AST与PNF独立相关。PNF评分=(0.000280×第1天AST)+(0.361×第1天乳酸)+(0.00884×第3天胆红素)+(0.940×第3天INR)+(0.00153×第7天AST)-(0.0972×移植白蛋白)-4.5503。受试者工作特征曲线分析显示,该模型的受试者工作特征曲线下面积(AUROC)为0.912(0.889 - 0.932),优于当前英国PNF标准的0.669(0.634 - 0.704,p < 0.0001)。当应用于一个验证队列(n = 386,34.4%的患者)时,该模型的AUROC为0.831(0.789 - 0.867),而英国早期移植肝功能障碍标准的AUROC为0.674(0.624 - 0.721)。在排除边缘性移植肝患者后,以及修改为仅纳入肝移植术后前三天的变量时,新模型表现良好(AUROC为0.818,0.776 - 0.856,p = 0.001)。该模型优于当前英国PNF标准,且基于统计方法。该模型也适用于所有类型移植肝(边缘性和非边缘性)的受者。